Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report.
作者信息
Rohla Miklos, Freynhofer Matthias K, Hammerl Herbert, Weiss Thomas W, Huber Kurt
机构信息
Miklos Rohla, 3rd Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria, Tel.: +43 1 49150 2301, Fax: +43 1 49150 2309, E-mail:
出版信息
Thromb Haemost. 2014 Feb;111(2):375-8. doi: 10.1160/TH13-06-0446. Epub 2013 Oct 17.
PMID:24136295
Abstract
摘要
相似文献
1
Stroke and recurrent left atrial appendage thrombus in a patient with atrial fibrillation under old and new oral anticoagulants: a case report.一名房颤患者在使用新旧口服抗凝剂时发生中风及复发性左心耳血栓：病例报告
Thromb Haemost. 2014 Feb;111(2):375-8. doi: 10.1160/TH13-06-0446. Epub 2013 Oct 17.
2
Dissolution of the left atrial appendage thrombus with rivaroxaban therapy.利伐沙班治疗左心耳血栓溶解
Cerebrovasc Dis. 2013;36(4):322-3. doi: 10.1159/000354315. Epub 2013 Oct 30.
3
Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?左心耳封堵术用于预防心房颤动患者的卒中：时机已成熟？
Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1587-9. doi: 10.1586/14779072.2013.846216.
4
Self-expandable device for percutaneous closing of left atrial appendage with organized thrombus in a patient with permanent atrial fibrillation.患者为永久性心房颤动，左心耳内有附壁血栓，经皮应用可膨胀装置进行左心耳封堵。
Can J Cardiol. 2013 Oct;29(10):1329.e1-1329.e3. doi: 10.1016/j.cjca.2012.09.016. Epub 2012 Dec 7.
5
Predictors of left atrial thrombosis in atrial fibrillation patients treated with direct oral anticoagulants.接受直接口服抗凝剂治疗的房颤患者左心房血栓形成的预测因素。
Acta Cardiol. 2023 May;78(3):371. doi: 10.1080/00015385.2022.2051879. Epub 2022 Mar 16.
6
Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated.左心耳封堵术：在无法耐受口服抗凝药时，房颤治疗的一种新选择。
Cleve Clin J Med. 2015 Mar;82(3):167-76. doi: 10.3949/ccjm.82a.14117.
7
Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives.左心耳封堵术后的抗栓管理：当前证据与未来展望。
Circ Cardiovasc Interv. 2023 May;16(5):e012812. doi: 10.1161/CIRCINTERVENTIONS.122.012812. Epub 2023 May 16.
8
Meta-analyses for oral anticoagulants and left atrial appendage thrombus resolution in nonvalvular atrial fibrillation: Piecing the puzzle together.非瓣膜性心房颤动中口服抗凝药与左心耳血栓溶解的荟萃分析：拼凑谜团。
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2261-2262. doi: 10.1111/jce.14568. Epub 2020 May 23.
9
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).达比加群酯的使用问题和其他新型口服抗凝剂在房颤患者中的使用展望。意大利血栓形成中心联合会（FCSA）的共识文件。
Thromb Haemost. 2011 Nov;106(5):868-76. doi: 10.1160/TH11-05-0358. Epub 2011 Sep 22.
10
Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation.CHA(2)DS(2)-VASc 和 HAS-BLED 评分对房颤患者抗栓治疗的影响。
Am J Med. 2011 Feb;124(2):111-4. doi: 10.1016/j.amjmed.2010.05.007. Epub 2010 Sep 29.
Zotero 插件